Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

David L. Lacey

Dr, Non-executive Director and Chairman of the R&D
Board of Directors
Biogazelle
Belgium

Biography

Dr. David L. Lacey has served as a member of our board of directors since July 2014. Dr. Lacey is a biopharmaceutical consultant at David L. Lacey LLC, where he advises academic institutions, biotechnology companies and venture capital firms, a position he has held since July 2011.

Research Interest

 He currently serves as a director of Inbiomotion SL, Atreca, Inc. and Nurix, Inc. From 1994 until his retirement in 2011, he held various positions, including head of discovery research, at Amgen Inc., where he played a fundamental scientific role in the discovery of the OPG/RANKL/RANK pathway, which led to the development of the anti-RANKL human mAb denosumab, for both osteoporosis (Prolia) and cancer-related bone diseases (XGEVA). He holds a Bachelor’s degree in biology and an M.D. from the University of Colorado, and has his board certification in anatomic pathology.

Global Experts from Belgium

Global Experts in Subject

Share This Profile
Recommended Journals
View more
Recommended Conferences
  • 6th European Biopharma Congress

    September 18-19, 2018 Amsterdam, Netherlands

  • 6th European Biopharma Congress

    September 18-19, 2018 Amsterdam, Netherlands

  • 5th International Conference on Pain Medicine and Pain Management

    October 17-18, 2018 New York, USA

  • 18th World Pharma Congress

    October 18-19, 2018 Warsaw, Poland

  • 18th World Pharma Congress

    October 18-19, 2018 Warsaw, Poland

  • 18th World Pharma Congress

    October 18-20, 2018 Warsaw, Poland

  • 18th World Pharma Congress

    October 18-20, 2018 Warsaw, Poland

  • 13th International Conference on Biosimilars and Biologics

    November 14-15, 2018 Lisbon, Portugal

View more
Relevant Topics